0001493152-21-021298.txt : 20210826
0001493152-21-021298.hdr.sgml : 20210826
20210826084525
ACCESSION NUMBER: 0001493152-21-021298
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210825
FILED AS OF DATE: 20210826
DATE AS OF CHANGE: 20210826
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Boehm Marcus
CENTRAL INDEX KEY: 0001850698
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35817
FILM NUMBER: 211208915
MAIL ADDRESS:
STREET 1: C/O VYANT BIO, INC.
STREET 2: 201 ROUTE 17 NORTH, 2ND FLOOR
CITY: RUTHERFORD
STATE: NJ
ZIP: 07070
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vyant Bio, Inc.
CENTRAL INDEX KEY: 0001349929
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 043462475
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2370 STATE ROUTE 70 WEST
STREET 2: SUITE 310
CITY: CHERRY HILL,
STATE: NJ
ZIP: 08002
BUSINESS PHONE: 201.528.9200
MAIL ADDRESS:
STREET 1: 2370 STATE ROUTE 70 WEST
STREET 2: SUITE 310
CITY: CHERRY HILL,
STATE: NJ
ZIP: 08002
FORMER COMPANY:
FORMER CONFORMED NAME: CANCER GENETICS, INC
DATE OF NAME CHANGE: 20111216
FORMER COMPANY:
FORMER CONFORMED NAME: CANCER GENETICS INC
DATE OF NAME CHANGE: 20060117
4
1
ownership.xml
X0306
4
2021-08-25
0
0001349929
Vyant Bio, Inc.
VYNT
0001850698
Boehm Marcus
C/O VYANT BIO, INC.
2370 STATE ROUTE 70, SUITE 310
CHERRY HILL,
NJ
08002
1
0
0
0
Common Stock, $0.0001 par value
2021-08-25
4
P
0
5000
2.5756
A
113786
I
By Trust
The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person under the Boehm Family Trust, Marcus & Kimberley Boehm Trustees on May 24, 2021.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.49 to $2.65 per share, inclusive. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
/s/ Andrew LaFrence, attorney-in-fact
2021-08-26